New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For NSRGY;PFE From The Last 14 Days
Check below for free stories on NSRGY;PFE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | all recent news | >>
April 17, 2014
08:38 EDTPFETeva settles patent ligitigation with Pfizer on Celebrex
Teva (TEVA) announced that its subsidiary Teva Pharmaceuticals USA, Inc. has entered into a settlement with Pfizer (PFE) related to Teva’s generic version of Celebrex 50, 100, 200 and 400 mg capsules in the United States. Under the terms of the settlement, Teva may launch its generic versions in December 2014 or earlier under certain circumstances. Teva has received tentative approval from the U.S. Food and Drug Administration for all strengths and believes that it is first-to-file on at least the 100, 200 and 400 mg capsules. Sales of Celebrex were $2.2B in the U.S. according to IMS data as of December, 2013.
06:28 EDTNSRGYNespresso agrees to change commercial behavior in France, WSJ reports
Subscribe for More Information
April 15, 2014
08:04 EDTPFEWuXi PharmaTech names Steve Yang as COO and Executive VP
Subscribe for More Information
06:32 EDTPFEPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link
05:10 EDTNSRGYNestle confirms FY14 organic growth guidance around 5%
Subscribe for More Information
05:08 EDTNSRGYNestle reports Q1 revenue CHF 20.8B vs. CHF 21.94B last year
Subscribe for More Information
April 14, 2014
09:05 EDTPFEGlycoMimetics presents GMI-1070 data
Subscribe for More Information
April 11, 2014
13:35 EDTNSRGYNestle chairman requires medical treatment
The Nestlé board of directors was informed yesterday that Peter Brabeck-Letmathe, chairman of the board, has been diagnosed with an illness which is curable but requires periodic medical treatment over the next six months. The company said that this does not affect Brabeck-Letmathe’s ability to carry out his role as chairman of the Nestlé board of directors and he will continue to fully exercise his duties during the treatment period. Reference Link
07:19 EDTPFEAcura Pharma to host conference call
Subscribe for More Information
April 10, 2014
12:04 EDTNSRGYNestle says slowdown could spark sales of underperforming units, WSJ says
Nestle plans to continue to to sell underperforming divisions as part of its on-going product-and-brand review, according to The Wall Street Journal, citing comments from CEO Paul Bulcke. CEO Bulcke said, "We are looking at our product and brand portfolio and analyzing it through a sharper, stricter lens. We are making choices about where we want to invest, where we want to improve and areas we want to divest." Reference Link
06:17 EDTPFEAcura Pharma announces return of product rights from Pfizer
Subscribe for More Information
<< 1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use